Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does childhood vaccination and exposure to infection improve long-term survival in patients with malignant melanoma?

Nature Clinical Practice Oncology volume 2, pages 240–241 (2005)Cite this article

boxed-textKölmel KF et al. (2005) Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer 41: 118–125

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Agarwala SS et al. (2004) Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I–III melanoma (E1673): a trial of the Eastern Oncology Group. Cancer 100: 1692–1698

    Article  CAS  Google Scholar 

  2. Hersey P et al. (2002) Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trial. J Clin Oncol 20: 4181–4190

    Article  CAS  Google Scholar 

  3. Wallack MK et al. (1998) Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial. J Am Coll Surg 187: 69–77

    Article  CAS  Google Scholar 

  4. Berwick M et al. (2005) Sun exposure and mortality from melanoma. J Natl Cancer Inst 97: 195–199

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. University of Pittsburgh Cancer Institute,

    Ahmad A Tarhini, Stephanie Land, Akshay Gupta & John M Kirkwood

  2. University of Pittsburgh Cancer Institute Melanoma Program and for the National Surgical Adjuvant Breast and Bowel Project,

    Ahmad A Tarhini, Stephanie Land, Akshay Gupta & John M Kirkwood

  3. University of Pittsburgh,

    Ahmad A Tarhini, Stephanie Land, Akshay Gupta & John M Kirkwood

  4. Department of Medicine,

    Ahmad A Tarhini, Stephanie Land, Akshay Gupta & John M Kirkwood

  5. Melanoma Center at the University of Pittsburgh Cancer Institute, PA, USA

    Ahmad A Tarhini, Stephanie Land, Akshay Gupta & John M Kirkwood

Authors
  1. Ahmad A Tarhini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie Land
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akshay Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John M Kirkwood
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John M Kirkwood.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Glossary

BCG (BACILLUS CALMETTE-GUÉRIN)

A live attenuated strain of Mycobacterium tuberculosis

FEBIM

FEBrile Infections and Melanoma

BRESLOW'S THICKNESS

Depth of melanoma penetration, measured from the outermost to innermost extent of the tumor; used to estimate survival after tumor excision

AJCC

American Joint Committee on Cancer

RCT

Randomized clinical trial

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tarhini, A., Land, S., Gupta, A. et al. Does childhood vaccination and exposure to infection improve long-term survival in patients with malignant melanoma?. Nat Rev Clin Oncol 2, 240–241 (2005). https://doi.org/10.1038/ncponc0175

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0175

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing